|
End-of-day quote
Shenzhen S.E.
21/08/2026
|
5-day change | 1st Jan Change | ||
| 7.080 CNY | +9.94% |
|
+17.22% | -3.93% |
| 02/06 | Beijing SL Pharmaceutical Co., Ltd. Approves Cash Dividend for 2025 | CI |
| 07/05 | Beijing SL Pharmaceutical Gets China Regulatory Nod for Xinfer Drug | MT |
| Market Cap | 7.27B 1.08B 927M 867M 794M 1.49B 104B 1.51B 10.25B 4B 52.01B 4.06B 3.97B 172B | P/E 2024 |
-107x | P/E 2025 | -21.7x |
|---|---|---|---|---|---|
| Enterprise Value | 6.13B 912M 781M 731M 669M 1.26B 87.28B 1.27B 8.64B 3.37B 43.85B 3.43B 3.35B 145B | EV / Sales 2024 |
8.62x | EV / Sales 2025 | 10.3x |
| Free-Float |
59.66% | Yield 2024 |
0.27% | Yield 2025 | 0.14% |
| 1 day | +9.94% | ||
| 1 week | +17.22% | ||
| Current month | +25.98% | ||
| 1 month | +26.65% | ||
| 3 months | +16.64% | ||
| 6 months | +11.32% | ||
| Current year | -3.93% |
| 1 week | 5.82 |  | 7.08 |
| 1 month | 5.22 | | 7.08 |
| Current year | 4.81 | | 9.4 |
| 1 year | 4.81 | | 9.4 |
| 3 years | 4.81 | | 16.09 |
| 5 years | 4.81 | | 16.09 |
| 10 years | 4.81 | | 33.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CEO | Chief Executive Officer | 62 | 11/04/2006 |
Li Ji
DFI | Director of Finance/CFO | 45 | 24/04/2023 |
Shu Jie Liang
SEC | Corporate Secretary | 60 | 11/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CHM | Chairman | 62 | 11/04/2006 |
Shu Jie Liang
BRD | Director/Board Member | 60 | 24/04/2009 |
Yu Lin Chen
BRD | Director/Board Member | 81 | 11/04/2006 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/11/25 | Buy | Director | 100 | 0.0000% | ||
| 29/10/25 | Sell | Director | 35,100 | 0.0041% | ||
| 28/10/25 | Sell | Director | 340,000 | 0.0399% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +9.94% | +17.22% | -12.92% | -22.11% | 1.08B | |
| +0.88% | +6.38% | +76.86% | +128.23% | 1,119B | |
| +1.07% | +3.80% | +51.03% | +61.48% | 651B | |
| +1.20% | +6.21% | +26.47% | +76.45% | 468B | |
| +1.02% | +5.77% | +43.09% | +47.70% | 374B | |
| +0.85% | +4.07% | +23.88% | +41.58% | 302B | |
| +1.26% | +6.81% | +1.59% | +14.67% | 259B | |
| +1.88% | +5.81% | +48.54% | +68.52% | 238B | |
| +1.59% | +2.09% | -15.52% | -52.29% | 208B | |
| +1.87% | +5.61% | +25.81% | +92.42% | 181B | |
| Average | +2.16% | +5.95% | +26.88% | +45.66% | 380.09B | |
| Weighted average by Cap. | +1.14% | +5.09% | +44.29% | +72.52% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 660M 98.24M 84.15M 78.74M 72.08M 135M 9.4B 137M 930M 363M 4.72B 369M 361M 15.62B | 624M 92.77M 79.47M 74.36M 68.06M 128M 8.88B 129M 878M 343M 4.46B 348M 341M 14.75B |
| Net income | -74.07M -11.02M -9.44M -8.83M -8.08M -15.17M -1.05B -15.37M -104M -40.69M -530M -41.37M -40.47M -1.75B | -347M -51.65M -44.24M -41.4M -37.89M -71.11M -4.94B -72.05M -489M -191M -2.48B -194M -190M -8.21B |
| Net Debt | -1.98B -295M -253M -236M -216M -406M -28.21B -411M -2.79B -1.09B -14.17B -1.11B -1.08B -46.88B | -1.14B -170M -145M -136M -125M -234M -16.24B -237M -1.61B -627M -8.16B -638M -624M -26.99B |
Employees
901
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/08/26 | CNY 7.080 | +9.94% | 58,576,037 |
| 20/08/26 | CNY 6.440 | +10.09% | 17,006,798 |
| 19/08/26 | CNY 5.850 | -3.47% | 25,701,164 |
| 18/08/26 | CNY 6.060 | -1.78% | 29,334,716 |
| 17/08/26 | CNY 6.170 | +2.15% | 34,432,375 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 002038 Stock
Select your edition
All financial news and data tailored to specific country editions
